Overall rank by patents
#32,646
Across all tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 19 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;).
The verdict
Nanovis holds 8 US patents across 19 technology areas, rank #32,646 of 50,000 tracked assignees.
Nanovis, Llc has been granted 8 US utility patents between 2016 and 2025, placing Nanovis, Llc at rank #32,646 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.8 claims per patent with primary concentration in A61L (METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES;). As a US Corporation, Nanovis, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Nanovis sits between Nano-master, Inc. (8 patents, rank #32,642) and Navigo Proteins Gmbh (8 patents, rank #32,650) - the closest US assignees by grant volume. The composite Innovation Score of 41.1/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 6 grants, compared with 2 in the 2015–2019 window, a +200% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Nanovis, Llc's 22.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Nanovis, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Nano-Master, Inc.
8 patents
Nanomedical Diagnostics, Inc.
8 patents
Nanostone Water Inc.
8 patents
Nanotech Security Corp.
8 patents
National Instruments Ireland Resources Limited
8 patents
National Kaohsiung First University of Science and Technology
8 patents
National Rehabilitation Center
8 patents
Navigo Proteins GmbH
8 patents
Nanovis, LLC
8 patents
What this shows Nanovis holds 8 patents at rank #32,646, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,646 in granted patent volume.
Other assignees with the most granted patents in Nanovis's primary technology class.
Nanovis's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 12.5% |
| 2018 | 1 | 12.5% |
| 2020 | 1 | 12.5% |
| 2021 | 2 | 25.0% |
| 2023 | 2 | 25.0% |
| 2025 | 1 | 12.5% |
Top 15 of 19 technology areas
Overall rank by patents
#32,646
Across all tracked assignees
41.1 out of 100
How to use this portfolio
Nanovis's 8 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.